RELIC TECHNOLOGIES LTD.

Listed on BSE under the Financial Services classification, Relic Technologies Limited is currently a holding-company structure with two subsidiaries — Relic Pharma Limited and Truhealthy Wellness Private Limited — operating in the pharma and wellness space. On a standalone basis, revenue from operations is nil: filings state the planned shift to pharma and wellness products has not yet started because the company is waiting for regulatory permissions. The operational activity sits in the consolidated books, where revenue from operations reached Rs. 220.07 lakhs in the first nine months of FY26, up about 46% year-on-year. The two subsidiaries together posted a pre-tax loss of Rs. 414.32 lakhs in 9M FY26, and the standalone entity swung to a full-year FY26 net loss of Rs. 694.49 lakhs against a profit of Rs. 54.20 lakhs in FY25, partly due to exceptional items of Rs. 232.12 lakhs. To fund the build-out, the company raised Rs. 1,692.48 lakhs via a preferential issue (equity plus convertible warrants) in FY26, of which Rs. 558 lakhs had been cumulatively utilised by March 2026 for working capital, investments, acquisitions and general corporate purposes. A related-party proposal seeks shareholder approval for transactions with Truhealthy Wellness of up to Rs. 10 crore in purchases/sales and Rs. 25 crore in loans. Employee cost is the dominant expense at 160.7% of standalone revenue, reflecting staff being on board while revenue-generating activity is still pending.